半年收获70亿美元订单,英硅智能签下武田制药,AI制药进入商业兑现新阶段

上观新闻
Jul 03

7月2日,港交所一纸公告让AI制药赛道再起波澜。  英硅智能宣布,与日本制药巨头武田制药达成全球战略合作,交易总金额最高可达6亿美元。受此消息刺激,英硅智能盘中一度大涨逾10%,较24.05港元的IPO发行价已接近翻倍。  这已是英硅智能2026年以来披露的第四笔重大BD(合作研发或对外授权)交易。从1月牵手施维雅斩获8.88亿美元,到3月结盟礼来拿下27.5亿美元,再到6月携手SK生物制药收获...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10